OBX|5000|ST|48013-7^Genomic reference sequence^LN|1a|NC_000001.11|
OBX|5001|NR|51959-5^Range(s) of DNA sequence examined^LN|1a.a|201038511^201113566|
OBX|5002|NR|51959-5^Range(s) of DNA sequence examined^LN|1a.b|201358007^201378700|
OBX|5003|ST|48013-7^Genomic reference sequence^LN|1b|NC_000002.12|
OBX|5004|NR|51959-5^Range(s) of DNA sequence examined^LN|1b.a|47402066^47484228|
OBX|5005|ST|48013-7^Genomic reference sequence^LN|1c|NC_000003.12|
OBX|5006|NR|51959-5^Range(s) of DNA sequence examined^LN|1c.a|36992349^37051846|
OBX|5007|ST|48013-7^Genomic reference sequence^LN|1d|NC_000005.10|
OBX|5008|NR|51959-5^Range(s) of DNA sequence examined^LN|1d.a|112706504^112847239|
OBX|5009|ST|48013-7^Genomic reference sequence^LN|1e|NC_000011.10|
OBX|5010|NR|51959-5^Range(s) of DNA sequence examined^LN|1e.a|47330405^47353702|
OBX|5011|NR|51959-5^Range(s) of DNA sequence examined^LN|1e.b|64802513^64812294|
OBX|5012|ST|48013-7^Genomic reference sequence^LN|1f|NC_000013.11|
OBX|5013|NR|51959-5^Range(s) of DNA sequence examined^LN|1f.a|32314479^32400672|
OBX|5014|ST|48013-7^Genomic reference sequence^LN|1g|NC_000014.9|
OBX|5015|NR|51959-5^Range(s) of DNA sequence examined^LN|1g.a|23411737^23436686|
OBX|5016|ST|48013-7^Genomic reference sequence^LN|1h|NC_000015.10|
OBX|5017|NR|51959-5^Range(s) of DNA sequence examined^LN|1h.a|63041638^63072915|
OBX|5018|ST|48013-7^Genomic reference sequence^LN|1i|NC_000017.11|
OBX|5019|NR|51959-5^Range(s) of DNA sequence examined^LN|1i.a|43043294^43126483|
OBX|5020|ST|48013-7^Genomic reference sequence^LN|1j|NC_000019.10|
OBX|5021|NR|51959-5^Range(s) of DNA sequence examined^LN|1j.a|1204798^1229435|
OBX|5022|NR|51959-5^Range(s) of DNA sequence examined^LN|1j.b|11088361^11134830|
OBX|5023|NR|51959-5^Range(s) of DNA sequence examined^LN|1j.c|38432699^38588564|
OBX|5024|NR|51959-5^Range(s) of DNA sequence examined^LN|1j.d|55150766^55158732|
OBX|5025|TX|51968-6^Genetic Analysis Overall Interpretation^UFMOLLRR|1|Positive|
OBX|5026|CWE|83005-9^Variant Category^LN|2a|LA26801-3^Simple^LN|
OBX|5027|ST|47998-0^Variant Display Name^LN|2a|NC_000005.10:112841058:T:A|
OBX|5028|CWE|48018-6^Gene Studied^UFMOLLRR|2a|HGNC:583^APC^HGNC|
OBX|5029|CWE|48004-6^DNA Change c.HGVS^LN|2a|NM_001127510.3:c.5465T>A|
OBX|5030|CWE|48005-3^Amino Acid Change p.HGVS^LN|2a|p.Val1822Asp|
OBX|5031|CWE|48013-7^Genomic reference sequence^UFMOLLRR|2a|NC_000005.10|
OBX|5032|ST|69547-8^Genomic ref allele^LN|2a|T|
OBX|5033|NR|81254-5^Genomic allele start-end^LN|2a|112841059|
OBX|5034|ST|69551-0^Genomic alt allele^LN|2a|A|
OBX|5035|ST|48000-4^Chromosome^LN|2a|5|
OBX|5036|CWE|48002-0^Genomic Source Class [Type]^LN|2a|LA6683-2^Germline^LN|
OBX|5037|CWE|81304-8^Variant Analysis Method [Type]^LN|2a|LA26398-0^Sequencing^LN|
OBX|5038|CWE|53037-8^Genetic Sequence Variation Clinical Significance^LN|2a|Benign|
OBX|5039|CWE|69548-6^Genetic Variant Assessment^LN|2a|LA9633-4^Present^LN|
OBX|5040|CWE|81259-4^Probable Associated Phenotype^LN|2a|72900001^Familial multiple polyposis syndrome^SCT|
OBX|5041|CWE|53034-5^Allelic state^LN|2a|LA6705-3^Homozygous^LN|
OBX|5042|CWE|83005-9^Variant Category^LN|2b|LA26801-3^Simple^LN|
OBX|5043|ST|47998-0^Variant Display Name^LN|2b|NC_000011.10:47348489:T:C|
OBX|5044|CWE|48018-6^Gene Studied^UFMOLLRR|2b|HGNC:7551^MYBPC3^HGNC|
OBX|5045|CWE|48004-6^DNA Change c.HGVS^LN|2b|NM_000256.3:c.706A>G|
OBX|5046|CWE|48005-3^Amino Acid Change p.HGVS^LN|2b|p.Ser236Gly|
OBX|5047|CWE|48013-7^Genomic reference sequence^UFMOLLRR|2b|NC_000011.10|
OBX|5048|ST|69547-8^Genomic ref allele^LN|2b|T|
OBX|5049|NR|81254-5^Genomic allele start-end^LN|2b|47348490|
OBX|5050|ST|69551-0^Genomic alt allele^LN|2b|C|
OBX|5051|ST|48000-4^Chromosome^LN|2b|11|
OBX|5052|CWE|48002-0^Genomic Source Class [Type]^LN|2b|LA6683-2^Germline^LN|
OBX|5053|CWE|81304-8^Variant Analysis Method [Type]^LN|2b|LA26398-0^Sequencing^LN|
OBX|5054|CWE|53037-8^Genetic Sequence Variation Clinical Significance^LN|2b|Likely benign|
OBX|5055|CWE|69548-6^Genetic Variant Assessment^LN|2b|LA9633-4^Present^LN|
OBX|5056|CWE|81259-4^Probable Associated Phenotype^LN|2b|35728003^Familial cardiomyopathy^SCT|
OBX|5057|CWE|53034-5^Allelic state^LN|2b|LA6706-1^Heterozygous^LN|
OBX|5058|CWE|83005-9^Variant Category^LN|2c|LA26801-3^Simple^LN|
OBX|5059|ST|47998-0^Variant Display Name^LN|2c|NC_000011.10:64804545:T:C|
OBX|5060|CWE|48018-6^Gene Studied^UFMOLLRR|2c|HGNC:7010^MEN1^HGNC|
OBX|5061|CWE|48004-6^DNA Change c.HGVS^LN|2c|NM_130800.2:c.1516A>G|
OBX|5062|CWE|48005-3^Amino Acid Change p.HGVS^LN|2c|p.Thr506Ala|
OBX|5063|CWE|48013-7^Genomic reference sequence^UFMOLLRR|2c|NC_000011.10|
OBX|5064|ST|69547-8^Genomic ref allele^LN|2c|T|
OBX|5065|NR|81254-5^Genomic allele start-end^LN|2c|64804546|
OBX|5066|ST|69551-0^Genomic alt allele^LN|2c|C|
OBX|5067|ST|48000-4^Chromosome^LN|2c|11|
OBX|5068|CWE|48002-0^Genomic Source Class [Type]^LN|2c|LA6683-2^Germline^LN|
OBX|5069|CWE|81304-8^Variant Analysis Method [Type]^LN|2c|LA26398-0^Sequencing^LN|
OBX|5070|CWE|53037-8^Genetic Sequence Variation Clinical Significance^LN|2c|Benign|
OBX|5071|CWE|69548-6^Genetic Variant Assessment^LN|2c|LA9633-4^Present^LN|
OBX|5072|CWE|81259-4^Probable Associated Phenotype^LN|2c|30664006^Multiple endocrine neoplasia, type 1^SCT|
OBX|5073|CWE|53034-5^Allelic state^LN|2c|LA6705-3^Homozygous^LN|
OBX|5074|CWE|83005-9^Variant Category^LN|2d|LA26801-3^Simple^LN|
OBX|5075|ST|47998-0^Variant Display Name^LN|2d|NC_000013.11:32355249:T:C|
OBX|5076|CWE|48018-6^Gene Studied^UFMOLLRR|2d|HGNC:1101^BRCA2^HGNC|
OBX|5077|CWE|48004-6^DNA Change c.HGVS^LN|2d|NM_000059.4:c.7397T>C|
OBX|5078|CWE|48005-3^Amino Acid Change p.HGVS^LN|2d|p.Val2466Ala|
OBX|5079|CWE|48013-7^Genomic reference sequence^UFMOLLRR|2d|NC_000013.11|
OBX|5080|ST|69547-8^Genomic ref allele^LN|2d|T|
OBX|5081|NR|81254-5^Genomic allele start-end^LN|2d|32355250|
OBX|5082|ST|69551-0^Genomic alt allele^LN|2d|C|
OBX|5083|ST|48000-4^Chromosome^LN|2d|13|
OBX|5084|CWE|48002-0^Genomic Source Class [Type]^LN|2d|LA6683-2^Germline^LN|
OBX|5085|CWE|81304-8^Variant Analysis Method [Type]^LN|2d|LA26398-0^Sequencing^LN|
OBX|5086|CWE|53037-8^Genetic Sequence Variation Clinical Significance^LN|2d|Benign|
OBX|5087|CWE|69548-6^Genetic Variant Assessment^LN|2d|LA9633-4^Present^LN|
OBX|5088|CWE|81259-4^Probable Associated Phenotype^LN|2d|718220008^Hereditary breast and ovarian cancer syndrome^SCT|
OBX|5089|CWE|53034-5^Allelic state^LN|2d|LA6705-3^Homozygous^LN|
OBX|5090|CWE|83005-9^Variant Category^LN|2e|LA26801-3^Simple^LN|
OBX|5091|ST|47998-0^Variant Display Name^LN|2e|NC_000019.10:38499669:C:T|
OBX|5092|CWE|48018-6^Gene Studied^UFMOLLRR|2e|HGNC:10483^RYR1^HGNC|
OBX|5093|CWE|48004-6^DNA Change c.HGVS^LN|2e|NM_001042723.2:c.7063C>T|
OBX|5094|CWE|48005-3^Amino Acid Change p.HGVS^LN|2e|p.Arg2355Trp|
OBX|5095|CWE|48013-7^Genomic reference sequence^UFMOLLRR|2e|NC_000019.10|
OBX|5096|ST|69547-8^Genomic ref allele^LN|2e|C|
OBX|5097|NR|81254-5^Genomic allele start-end^LN|2e|38499670|
OBX|5098|ST|69551-0^Genomic alt allele^LN|2e|T|
OBX|5099|ST|48000-4^Chromosome^LN|2e|19|
OBX|5100|CWE|48002-0^Genomic Source Class [Type]^LN|2e|LA6683-2^Germline^LN|
OBX|5101|CWE|81304-8^Variant Analysis Method [Type]^LN|2e|LA26398-0^Sequencing^LN|
OBX|5102|CWE|53037-8^Genetic Sequence Variation Clinical Significance^LN|2e|Pathogenic|
OBX|5103|CWE|69548-6^Genetic Variant Assessment^LN|2e|LA9633-4^Present^LN|
OBX|5104|CWE|81259-4^Probable Associated Phenotype^LN|2e|405501007^Malignant hyperthermia^SCT|
OBX|5105|CWE|53034-5^Allelic state^LN|2e|LA6706-1^Heterozygous^LN|
